138 related articles for article (PubMed ID: 20411566)
1. Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection.
Leligdowicz A; Onyango C; Yindom LM; Peng Y; Cotten M; Jaye A; McMichael A; Whittle H; Dong T; Rowland-Jones S
Eur J Immunol; 2010 Jul; 40(7):1963-72. PubMed ID: 20411566
[TBL] [Abstract][Full Text] [Related]
2. Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.
de Silva TI; Peng Y; Leligdowicz A; Zaidi I; Li L; Griffin H; Blais ME; Vincent T; Saraiva M; Yindom LM; van Tienen C; Easterbrook P; Jaye A; Whittle H; Dong T; Rowland-Jones SL
Blood; 2013 May; 121(21):4330-9. PubMed ID: 23558015
[TBL] [Abstract][Full Text] [Related]
3. HLA-E-restricted, Gag-specific CD8
Yang H; Rei M; Brackenridge S; Brenna E; Sun H; Abdulhaqq S; Liu MKP; Ma W; Kurupati P; Xu X; Cerundolo V; Jenkins E; Davis SJ; Sacha JB; Früh K; Picker LJ; Borrow P; Gillespie GM; McMichael AJ
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33766848
[TBL] [Abstract][Full Text] [Related]
4. Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.
Riou C; Ganusov VV; Campion S; Mlotshwa M; Liu MK; Whale VE; Goonetilleke N; Borrow P; Ferrari G; Betts MR; Haynes BF; McMichael AJ; Gray CM
J Immunol; 2012 Mar; 188(5):2198-206. PubMed ID: 22287716
[TBL] [Abstract][Full Text] [Related]
5. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
[TBL] [Abstract][Full Text] [Related]
6. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
Pettersen FO; Taskén K; Kvale D
Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
[TBL] [Abstract][Full Text] [Related]
7. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
8. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
9. Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infection.
Moysi E; Darko S; Gea-Mallorquí E; Petrovas C; Almeida JR; Wolinsky D; Peng Y; Jaye A; Stewart-Jones G; Douek DC; Koup RA; Dong T; Rowland-Jones S
Eur J Immunol; 2021 Oct; 51(10):2485-2500. PubMed ID: 34369597
[TBL] [Abstract][Full Text] [Related]
10. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
11. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
[TBL] [Abstract][Full Text] [Related]
12. Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.
Ghiglione Y; Falivene J; Ruiz MJ; Laufer N; Socías ME; Cahn P; Giavedoni L; Sued O; Gherardi MM; Salomón H; Turk G
PLoS One; 2014; 9(8):e104235. PubMed ID: 25093660
[TBL] [Abstract][Full Text] [Related]
13. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection.
Scharf L; Tauriainen J; Buggert M; Hartogensis W; Nolan DJ; Deeks SG; Salemi M; Hecht FM; Karlsson AC
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350076
[TBL] [Abstract][Full Text] [Related]
14. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
[TBL] [Abstract][Full Text] [Related]
15. A Novel Immunogen Selectively Eliciting CD8
Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
[TBL] [Abstract][Full Text] [Related]
16. Terminally differentiated CD8 cells in HIV-infected children: HIV-GAG/POL specificity and IFN-γ production.
Delbeck D; Siepermann M; Feyen O; Wirth S; Baumann U; Wintergerst U; Oette M; Adam R; Jetzek-Zader M; Niehues T
Klin Padiatr; 2011 Jul; 223(4):214-20. PubMed ID: 21472637
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*14:02-Restricted Env-Specific CD8
Leitman EM; Willberg CB; Tsai MH; Chen H; Buus S; Chen F; Riddell L; Haas D; Fellay J; Goedert JJ; Piechocka-Trocha A; Walker BD; Martin J; Deeks S; Wolinsky SM; Martinson J; Martin M; Qi Y; Sáez-Cirión A; Yang OO; Matthews PC; Carrington M; Goulder PJR
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878089
[TBL] [Abstract][Full Text] [Related]
18. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
19. In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4
Ngu LN; Nji NN; Ambada GE; Sagnia B; Sake CN; Tchadji JC; Njambe Priso GD; Lissom A; Tchouangueu TF; Manga Tebit D; Waffo AB; Park CG; Steinman RM; Überla K; Nchinda GW
Immun Inflamm Dis; 2019 Jun; 7(2):55-67. PubMed ID: 28474788
[TBL] [Abstract][Full Text] [Related]
20. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
